Zentek Corp (ZTEK) - Long-Term Liabilities to Capital

Corporate emblem and logo of Zentek Corp (ZTEK)

The dynamics of long-term debt relative to equity reflect the impact of FDA delays and sales scaling challenges. Meanwhile, Zentek Ltd. relies on its team of nanotechnologists and ESG-driven environmental remediation solutions. The value of 0.07 represents the latest metric level, helping to assess the financial autonomy of Zentek Ltd. amid the development of innovative antimicrobial coatings.

Zentek Limited - ZTEK Long-Term Debt to Capital (period 04/28/2023 - 09/12/2026)

Comprehensive metric breakdowns and analytics for Zentek Ltd. (ZTEK)

- stock value and consensus price forecast:
Stock Quotes Zentek Ltd|ZTEK - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Zentek Ltd.|ZTEK - Enterprise Value
- book value of equity indicators:
Equity per Share Zentek|ZTEK - Book Capitalization|Market Capitalization to Book Value zentek.com|ZTEK - Company Total Assets
- debt and solvency information:
Total Debt to Equity Ratio Zentek Ltd.|ZTEK - Long-Term Debt to Capital|Short-Term Debt to Capital zentek.com|ZTEK - Company Debts|Debt to Book Capitalization Ratio Zentek Ltd.|ZTEK - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Zentek|Interim Coverage Ratio zentek.com
- financial results and valuation multiples details:
ZTEK - Company Net Income
Comprehensive company analysis:Zentek Ltd
Signature product of Zentek Ltd.

To build a resilient portfolio, I evaluate financial leverage through the ratio of liabilities with a maturity exceeding one year to equity. This metric determines the extent of a company's dependence on external long-term financing. For Zentek Ltd. (ZTEK), which invests in multi-industry graphene nanomaterials, this balance is critical when scaling R&D. By analyzing the structure of long-term debt relative to equity, an investor can distinguish strategic development from insolvency risks.

Competing companies

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc. (ISRG)|Long-Term Debt to Capital DHR|BDX - Long-Term Liabilities to Capital|Long-Term Debt to Capital STE (STERIS plc)|WST: Long-Term Debt to Capital Ratio|Baxter - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Masimo Corp MASI|STVN: Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Teleflex Corp|MMSI (Merit Medical Systems) - Long-Term Debt to Capital|Long-Term Debt to Capital envistaco.com|Long-Term Debt to Equity ICU Medical (ICUI)|Long-Term Debt to Equity XRAY (Dentsply Sirona Inc)|LeMaitre - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient ATRC|STAAR Surgical Company - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital ChromaDex Corp NAGE|ZimVie (ZIMV) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio ANGO|Long-Term Debt to Equity Cerus Corp|Teknova Inc (TKNO) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio MGRM (Monogram Technologies)|Long-Term Loans to Capital Ratio STSS|Long-Term Debt to Equity InfuSystem Holdings, Inc. INFU|Long-Term Debt to Capital Coefficient UTMD|KRMD: Long-Term Debt to Equity Ratio|NYXH - Long-Term Debt to Capital|Microbot Medical Inc. (MBOT) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio pro-dex.com|ELUT (Elutia) - Long-Term Debt to Capital|Long-Term Liabilities to Capital Milestone Scientific Inc MLSS|Long-Term Debt to Equity NEXGEL, Inc (NXGL)|retractable.com - Long-Term Debt to Capital Ratio|Harvard Bioscience, Inc. - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio FEMY (femasys.com)|MHUA - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Predictive Oncology POAI|CJMB (callanjmb.com) - Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity ATRI (Atrion Corporation Inc.)|NURO (NeuroMetrix, Inc.) - Long-Term Debt to Capital